Novo Holdings A/S - 16 Jun 2021 Form 3 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
10%+ Owner
Signature
/s/ Peter Haahr, Chief Financial Officer of Novo Holdings A/S
Issuer symbol
VERV
Transactions as of
16 Jun 2021
Net transactions value
$0
Form type
3
Filing time
16 Jun 2021, 17:18:14 UTC
Previous filing
03 Jun 2021
Next filing
17 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VERV SERIES B CONVERTIBLE PREFERRED STOCK 16 Jun 2021 COMMON STOCK 443,265 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series B Convertible Preferred Stock will convert automatically into one share of common stock upon the closing of the Issuer's initial public offering. These shares have no expiration date.